Managing early growth restriction: blood tests vs ultrasound
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and pregnant with a single baby.
- Between 26 and 31 weeks of pregnancy, an ultrasound showed your baby's estimated weight was in the 10th percentile or lower.
- Your pregnancy dating is confirmed by an early ultrasound (or IVF dates).
- You do not have a baby with major physical or genetic abnormalities.
- You have not had a fetal death, and your baby is not in stage IV (most severe) fetal growth restriction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study uses special imaging techniques to look at the placenta during pregnancy. It aims to learn more about normal pregnancies and those where the baby is growing more slowly than expected.
This study compares a computer-based analysis of the baby's heart rate tracing (called STV) with the standard visual check doctors perform. The goal is to see if the computer method better identifies babies who are struggling, so doctors can act sooner to keep the baby safe.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
This study looks at babies in monochorionic (shared-placenta) twin pregnancies where one or both babies are growing too slowly. It aims to better understand this condition and follow families over time to improve care, with check-ins through age 2 after birth.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.